Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Julia M.L. Brotherton, Mark Jit, Patti E. Gravitt, Marc Brisson, Aimée R. Kreimer, Sara Isabel Pai, Carole Fakhry, Joseph Monsonego, Silvia Franceschi

Research output: Contribution to journalReview article

Abstract

This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.

Original languageEnglish (US)
Pages (from-to)510-517
Number of pages8
JournalInternational Journal of Cancer
Volume139
Issue number3
DOIs
StatePublished - Aug 1 2016

Keywords

  • HPV
  • cervical cancer
  • oropharyngeal cancer
  • vaccine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines'. Together they form a unique fingerprint.

  • Cite this

    Brotherton, J. M. L., Jit, M., Gravitt, P. E., Brisson, M., Kreimer, A. R., Pai, S. I., Fakhry, C., Monsonego, J., & Franceschi, S. (2016). Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines. International Journal of Cancer, 139(3), 510-517. https://doi.org/10.1002/ijc.30063